Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuzo Hamamoto

Showing results (141-150 of 185) with videos related to

Pageof 19
Sort By:
Oncology|July 20, 2021
First Report of Oncological Outcome and Prognostic Analysis in a First-Line Setting of Short Hydration Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Urothelial CarcinomaTaku Naiki, Takashi Nagai, Yosuke Sugiyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 26, 2024
Defining a learning curve for urology trainees to achieve renal access without complications in endoscopic combined intrarenal surgeryTakahiro Yanase, Kazumi Taguchi, Teruaki Sugino, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 24, 2025
The Effectiveness and Safety Profile of Nivolumab-Plus-Ipilimumab in Previously Untreated Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma (J-ENCORE Study)Koshiro Nishimoto, Go Kimura, Tomokazu Sazuka, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 26, 2026
Enhanced magnetic hyperthermia using anti-PD-L1 antibody-conjugated magnetoliposomes in a murine subcutaneous bladder cancer modelMasakazu Gonda, Noriyasu Kawai, Daiki Ishikawa, et al.
Annals of Surgical Oncology|December 19, 2025
Mental Stress Assessment and Clinical Application of Wearable Devices as Evaluable Outcomes in Robotic ProstatectomyTaku Naiki, Yoshihisa Mimura, Yosuke Sugiyama, et al.
BMC Urology|July 12, 2024
Using fosfomycin to prevent infection following ureterorenoscopy in response to shortage of cephalosporins: a retrospective preliminary studyToshiki Etani, Chiharu Wachino, Takuya Sakata, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 26, 2025
Outcomes of Nivolumab-Plus-Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J-ENCORE StudyTomokazu Sazuka, Katsunori Tatsugami, Suguru Shirotake, et al.
Journal of Endourology|May 14, 2025
Effect of Using Automated Irrigation Systems on the Risk of Infectious Complications after Endoscopic Combined Intrarenal Surgery: A Retrospective Cohort StudyChatporn Boonyapalanant, Rei Unno, Kazumi Taguchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 17, 2026
A Minimum 3-Year Follow-Up of Nivolumab-Plus-Ipilimumab in Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma: A Final Analysis of the J-ENCORE StudyShuzo Hamamoto, Masahiro Nozawa, Suguru Shirotake, et al.
Frontiers in Immunology|January 24, 2025
Eosinophil is a predictor of severe immune-related adverse events induced by ipilimumab plus nivolumab therapy in patients with renal cell carcinoma: a retrospective multicenter cohort studyYoshihiko Tasaki, Shuzo Hamamoto, Shimpei Yamashita, et al.
Pageof 19

Showing results (141-150 of 185) with videos related to

Sort By:
Pageof 19
Oncology|July 20, 2021
First Report of Oncological Outcome and Prognostic Analysis in a First-Line Setting of Short Hydration Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Urothelial CarcinomaTaku Naiki, Takashi Nagai, Yosuke Sugiyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 26, 2024
Defining a learning curve for urology trainees to achieve renal access without complications in endoscopic combined intrarenal surgeryTakahiro Yanase, Kazumi Taguchi, Teruaki Sugino, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 24, 2025
The Effectiveness and Safety Profile of Nivolumab-Plus-Ipilimumab in Previously Untreated Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma (J-ENCORE Study)Koshiro Nishimoto, Go Kimura, Tomokazu Sazuka, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 26, 2026
Enhanced magnetic hyperthermia using anti-PD-L1 antibody-conjugated magnetoliposomes in a murine subcutaneous bladder cancer modelMasakazu Gonda, Noriyasu Kawai, Daiki Ishikawa, et al.
Annals of Surgical Oncology|December 19, 2025
Mental Stress Assessment and Clinical Application of Wearable Devices as Evaluable Outcomes in Robotic ProstatectomyTaku Naiki, Yoshihisa Mimura, Yosuke Sugiyama, et al.
BMC Urology|July 12, 2024
Using fosfomycin to prevent infection following ureterorenoscopy in response to shortage of cephalosporins: a retrospective preliminary studyToshiki Etani, Chiharu Wachino, Takuya Sakata, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 26, 2025
Outcomes of Nivolumab-Plus-Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J-ENCORE StudyTomokazu Sazuka, Katsunori Tatsugami, Suguru Shirotake, et al.
Journal of Endourology|May 14, 2025
Effect of Using Automated Irrigation Systems on the Risk of Infectious Complications after Endoscopic Combined Intrarenal Surgery: A Retrospective Cohort StudyChatporn Boonyapalanant, Rei Unno, Kazumi Taguchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 17, 2026
A Minimum 3-Year Follow-Up of Nivolumab-Plus-Ipilimumab in Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma: A Final Analysis of the J-ENCORE StudyShuzo Hamamoto, Masahiro Nozawa, Suguru Shirotake, et al.
Frontiers in Immunology|January 24, 2025
Eosinophil is a predictor of severe immune-related adverse events induced by ipilimumab plus nivolumab therapy in patients with renal cell carcinoma: a retrospective multicenter cohort studyYoshihiko Tasaki, Shuzo Hamamoto, Shimpei Yamashita, et al.
Pageof 19